Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1491 Articles

Chris Lange | May 25, 2017 at 9:45 AM EDT

Major Pharma Short Interest Surges

The May 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Jon C. Ogg | May 20, 2017 at 8:15 AM EDT

10 Stocks Analysts Want You to Sell

These are the top 10 Sell equivalent ratings seen from analysts during the week of May 15 to May 19,…

Paul Ausick | May 16, 2017 at 4:01 PM EDT

UnitedHealth, Nike Weigh on DJIA Tuesday

UnitedHealth, Nike, Pfizer, and Wal-Mart led the DJIA to a modest decline Tuesday.

Jon C. Ogg | May 16, 2017 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: AIG, Exact Sciences, MercadoLibre, Pfizer, Whole Foods, Valero Energy, Yum Brands and More

The the top analyst upgrades, downgrades and other research calls from Tuesday include AIG, Exact Sciences, MercadoLibre, Pfizer, Whole Foods,…

Paul Ausick | May 15, 2017 at 11:35 AM EDT

Top Credit Suisse Pharma Picks Ahead of Catalysts

Credit Suisse provided its outlook for several large-cap pharmaceutical stocks Monday morning. The analyst has three top picks to consider.

Trey Thoelcke | May 11, 2017 at 11:40 AM EDT

Why Big Pharma Is Not at Fault for Record Drug Spending

With prescription drug spending breaking new records almost every year now, people like to blame Big Pharma and use it…

Chris Lange | May 11, 2017 at 10:30 AM EDT

Why Sangamo Therapeutics Is Surging

Sangamo Therapeutics saw its shares skyrocket early on Thursday after a critical business update.

Chris Lange | May 10, 2017 at 9:00 AM EDT

Short Interest in Major Pharma Shrinks

The April 28 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | May 2, 2017 at 8:50 AM EDT

Pfizer Sinks on Mixed Q1 Earnings

Pfizer reported mixed first-quarter financial results before the markets opened on Tuesday.

Chris Lange | May 1, 2017 at 11:30 AM EDT

What to Expect From Apple and More Dow Stocks Reporting on Tuesday

24/7 Wall St. has put together a preview of the Dow Jones Industrial Average companies scheduled to report their quarterly…

Chris Lange | Apr 30, 2017 at 9:25 AM EDT

Facebook, Tesla and More Major Earnings Coming Out This Week

24/7 Wall St. has put together a preview of Apple, Facebook, Pfizer and some of the other top companies reporting…

Chris Lange | Apr 26, 2017 at 8:25 AM EDT

Short Sellers Can’t Make Up Their Minds on Major Pharma

The April 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Apr 12, 2017 at 8:25 AM EDT

Short Sellers Run for Cover From Major Pharma Stocks

The March 31 short interest data have been compared with the previous figures, and short interest decreased in most of…

Paul Ausick | Apr 11, 2017 at 4:01 PM EDT

Apple, DuPont Sink DJIA Tuesday

Apple, DuPont, Goldman Sachs, and Pfizer led the DJIA to a lower close on Tuesday.

Chris Lange | Mar 27, 2017 at 8:35 AM EDT

Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote

The March 15 short interest data have been compared with the previous figures, and short interest in most of these…

1 … 41 42 43 44 45 … 100

Pfizer : PFE

All Pfizer Articles

Major Pharma Short Interest Surges

10 Stocks Analysts Want You to Sell

UnitedHealth, Nike Weigh on DJIA Tuesday

Top Analyst Upgrades and Downgrades: AIG, Exact Sciences, MercadoLibre, Pfizer, Whole Foods, Valero Energy, Yum Brands and More

Top Credit Suisse Pharma Picks Ahead of Catalysts

Why Big Pharma Is Not at Fault for Record Drug Spending

Why Sangamo Therapeutics Is Surging

Short Interest in Major Pharma Shrinks

Pfizer Sinks on Mixed Q1 Earnings

What to Expect From Apple and More Dow Stocks Reporting on Tuesday

Facebook, Tesla and More Major Earnings Coming Out This Week

Short Sellers Can’t Make Up Their Minds on Major Pharma

Short Sellers Run for Cover From Major Pharma Stocks

Apple, DuPont Sink DJIA Tuesday

Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

EEM’s 0.69% Fee Quietly Costs You $690 a Year, but Your Cheaper Alternative Charges $90

'You're Gonna Go Into Retirement Broke and Wait on Mom to Die': Dave Ramsey's Reality Check for a Caller Eyeing His Inheritance

"You Don't Want to Pass the Burden of Investments Down to Your Daughter": Suze Orman's Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

Pfizer : PFE

All Pfizer Articles

Major Pharma Short Interest Surges

10 Stocks Analysts Want You to Sell

UnitedHealth, Nike Weigh on DJIA Tuesday

Top Analyst Upgrades and Downgrades: AIG, Exact Sciences, MercadoLibre, Pfizer, Whole Foods, Valero Energy, Yum Brands and More

Top Credit Suisse Pharma Picks Ahead of Catalysts

Why Big Pharma Is Not at Fault for Record Drug Spending

Why Sangamo Therapeutics Is Surging

Short Interest in Major Pharma Shrinks

Pfizer Sinks on Mixed Q1 Earnings

What to Expect From Apple and More Dow Stocks Reporting on Tuesday

Facebook, Tesla and More Major Earnings Coming Out This Week

Short Sellers Can’t Make Up Their Minds on Major Pharma

Short Sellers Run for Cover From Major Pharma Stocks

Apple, DuPont Sink DJIA Tuesday

Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

EEM’s 0.69% Fee Quietly Costs You $690 a Year, but Your Cheaper Alternative Charges $90

Featured Reads

'You're Gonna Go Into Retirement Broke and Wait on Mom to Die': Dave Ramsey's Reality Check for a Caller Eyeing His Inheritance

"You Don't Want to Pass the Burden of Investments Down to Your Daughter": Suze Orman's Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings